Insider Trading Activity Charles River Laboratories International, Inc. (NYSE:CRL) – Director Sold 3,830 shares of Stock

ME Staff
-
0

Insider Trading Activity For Charles River Laboratories International, Inc. (NYSE:CRL)

George Massaro , Director of Charles River Laboratories International, Inc. (NYSE:CRL) reportedly Sold 3,830 shares of the company’s stock at an average price of 100.81 for a total transaction amount of $386,102.30 SEC Form

Insider Trading History For Charles River Laboratories International, Inc. (NYSE:CRL)

  • On 3/13/2013 David P Johst, VP, sold 17,038 with an average share price of $45.00 per share and the total transaction amounting to $766,710.00.View SEC Filing
  • On 5/10/2013 George Massaro, Director, sold 2,020 with an average share price of $44.09 per share and the total transaction amounting to $89,061.80.View SEC Filing
  • On 5/14/2013 James C Foster, CEO, sold 113,810 with an average share price of $45.00 per share and the total transaction amounting to $5,121,450.00.View SEC Filing
  • On 6/3/2013 Thomas F Ackerman, CFO, sold 4,000 with an average share price of $42.40 per share and the total transaction amounting to $169,600.00.View SEC Filing
  • On 8/2/2013 Thomas Ackerman, CFO, sold 26,250 with an average share price of $46.03 per share and the total transaction amounting to $1,208,287.50.View SEC Filing
  • On 8/2/2013 Deborah Turner Kochevar, Director, sold 4,447 with an average share price of $46.02 per share and the total transaction amounting to $204,650.94.View SEC Filing
  • On 8/2/2013 Davide Molho, VP, sold 4,100 with an average share price of $45.89 per share and the total transaction amounting to $188,149.00.View SEC Filing

    • Analyst Ratings For Charles River Laboratories International, Inc. (NYSE:CRL)
    These are 4 Hold Ratings, 3 Buy Ratings .
    The current consensus rating for Charles River Laboratories International, Inc. (NYSE:CRL) is Hold (Score: 2.43) with a consensus target price of $95.21 , a potential (5.45% downside)

    Analyst Ratings History For Charles River Laboratories International, Inc. (NYSE:CRL)

    • On 8/28/2015 William Blair Reiterated Rating Outperform
    • On 1/7/2016 Wells Fargo & Company Upgraded rating Market Perform to Outperform
    • On 1/8/2016 Robert W. Baird Boost Price Target of rating Outperform with a price target of $86.00 to $92.00
    • On 2/11/2016 Deutsche Bank AG Reiterated Rating Hold with a price target of $85.00 to $82.00
    • On 4/26/2016 Gabelli Initiated Coverage of rating Buy with a price target of $96.00
    • On 5/22/2016 KeyCorp Reiterated Rating Hold with a price target of $77.00
    • On 11/18/2016 Bank of America Corporation Set Price Target of rating Buy with a price target of $93.00

    Recent Trading Activity for Charles River Laboratories International, Inc. (NYSE:CRL)
    Shares of Charles River Laboratories International, Inc. closed the previous trading session at 100.00 down -0.70 -0.70% with 158,196 shares trading hands.